neomycin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antibiotics, produced by Streptomyces strains 4247 1405-10-3

Description:

MoleculeDescription

Synonyms:

  • neomycin sulfate
  • neomycin
  • bykomycin
  • endomixin
  • fradiomycin sulfate
  • mycerin sulfate
  • neomycin sulphate
  • neomycin palmitate
Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.
  • Molecular weight: 1551.66
  • Formula: C58H118N16O32
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
5 g O
1 g P

ADMET properties:

PropertyValueReference
BA (Bioavailability) 3 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
March 26, 1957 FDA MONARCH PHARMS

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug hypersensitivity 383.94 16.47 373 11461 310314 63166874
Macular degeneration 258.42 16.47 114 11720 24262 63452926
Toxic anterior segment syndrome 96.70 16.47 28 11806 1743 63475445
Type 2 diabetes mellitus 86.43 16.47 81 11753 63787 63413401
C-reactive protein 79.33 16.47 31 11803 4851 63472337
Swollen joint count increased 61.21 16.47 52 11782 36002 63441186
Rheumatic fever 55.10 16.47 53 11781 43058 63434130
Chronic sinusitis 48.28 16.47 30 11804 12813 63464375
Lip dry 47.94 16.47 32 11802 15438 63461750
Helicobacter infection 46.69 16.47 71 11763 92714 63384474
Deep vein thrombosis postoperative 46.42 16.47 28 11806 11341 63465847
Sciatica 45.38 16.47 43 11791 34281 63442907
Blood cholesterol increased 43.19 16.47 69 11765 93963 63383225
Fibromyalgia 42.54 16.47 63 11771 80357 63396831
Live birth 39.52 16.47 35 11799 25595 63451593
Autoimmune disorder 38.14 16.47 29 11805 17148 63460040
Paraesthesia oral 37.32 16.47 30 11804 19226 63457962
Hypercholesterolaemia 36.67 16.47 31 11803 21303 63455885
Prescribed overdose 36.30 16.47 38 11796 34115 63443073
Procedural pain 34.34 16.47 30 11804 21539 63455649
Injury 33.97 16.47 54 11780 73193 63403995
Mobility decreased 30.74 16.47 69 11765 121090 63356098
Road traffic accident 29.06 16.47 35 11799 36597 63440591
Rheumatoid factor positive 28.39 16.47 54 11780 84352 63392836
Sleep disorder due to general medical condition, insomnia type 27.74 16.47 41 11793 52176 63425012
Lower limb fracture 27.63 16.47 28 11806 24193 63452995
Infusion related reaction 27.28 16.47 104 11730 245417 63231771
Duodenal ulcer perforation 27.15 16.47 54 11780 87155 63390033
Intentional product use issue 26.16 16.47 67 11767 127825 63349363
Heart sounds 26.12 16.47 9 11825 987 63476201
Osteoarthritis 26.11 16.47 56 11778 95287 63381901
Prolonged expiration 25.28 16.47 9 11825 1087 63476101
Nail bed tenderness 24.72 16.47 7 11827 402 63476786
Toxicity to various agents 24.14 16.47 8 11826 247242 63229946
Septic arthritis staphylococcal 23.71 16.47 7 11827 466 63476722
Facet joint syndrome 23.71 16.47 19 11815 12119 63465069
Liver injury 21.95 16.47 40 11794 60480 63416708
Adverse event 21.22 16.47 42 11792 67517 63409671
Autonomic neuropathy 21.11 16.47 8 11826 1151 63476037
Swelling 20.89 16.47 104 11730 275274 63201914
Oedema 20.85 16.47 52 11782 97570 63379618
Lymphatic disorder 20.69 16.47 6 11828 375 63476813
Hip arthroplasty 20.55 16.47 34 11800 47612 63429576
Wheezing 20.50 16.47 51 11783 95544 63381644
Folliculitis 20.05 16.47 42 11792 70275 63406913
Psoriatic arthropathy 19.81 16.47 49 11785 91471 63385717
Vaginal flatulence 18.52 16.47 10 11824 3283 63473905
Drug interaction 18.24 16.47 10 11824 229121 63248067
General physical health deterioration 18.15 16.47 80 11754 201322 63275866
Irritable bowel syndrome 17.70 16.47 44 11790 82368 63394820
Liver disorder 17.62 16.47 34 11800 53653 63423535
Lupus vulgaris 17.61 16.47 12 11822 5982 63471206
Knee arthroplasty 17.39 16.47 34 11800 54172 63423016
Therapeutic product effect decreased 16.85 16.47 76 11758 193111 63284077
Therapy non-responder 16.80 16.47 41 11793 75860 63401328
Product use in unapproved indication 16.79 16.47 72 11762 179008 63298180
Adverse drug reaction 16.53 16.47 42 11792 79672 63397516
Depressive symptom 16.48 16.47 10 11824 4092 63473096

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug hypersensitivity 71.99 17.38 63 3634 80466 34872768
Staphylococcal skin infection 32.11 17.38 9 3688 885 34952349
Staphylococcal scalded skin syndrome 25.63 17.38 6 3691 287 34952947
Retinitis 23.75 17.38 6 3691 396 34952838
Renal injury 19.35 17.38 13 3684 11182 34942052
Mucosal inflammation 19.17 17.38 22 3675 38600 34914634
Vanishing bile duct syndrome 18.24 17.38 6 3691 1012 34952222
Multiple organ dysfunction syndrome 17.45 17.38 30 3667 76536 34876698

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug hypersensitivity 250.61 14.78 272 12487 298644 79432985
Toxic anterior segment syndrome 101.23 14.78 31 12728 2733 79728896
C-reactive protein 79.69 14.78 30 12729 4949 79726680
Swollen joint count increased 74.07 14.78 46 12713 22881 79708748
Rheumatic fever 67.24 14.78 47 12712 28478 79703151
Macular degeneration 64.70 14.78 33 12726 11263 79720366
Type 2 diabetes mellitus 52.93 14.78 55 12704 57067 79674562
Injury 50.29 14.78 62 12697 77434 79654195
Sciatica 50.18 14.78 42 12717 33180 79698449
Lip dry 47.44 14.78 30 12729 15388 79716241
Chronic sinusitis 46.85 14.78 28 12731 12998 79718631
Paraesthesia oral 46.54 14.78 33 12726 20438 79711191
Deep vein thrombosis postoperative 43.65 14.78 25 12734 10727 79720902
Rheumatoid factor positive 39.02 14.78 48 12711 59791 79671838
Procedural pain 38.67 14.78 31 12728 23053 79708576
Autoimmune disorder 38.28 14.78 27 12732 16585 79715044
Live birth 37.57 14.78 28 12731 18716 79712913
Duodenal ulcer perforation 35.17 14.78 48 12711 66163 79665466
Drug interaction 34.01 14.78 12 12747 415171 79316458
Road traffic accident 31.70 14.78 37 12722 43627 79688002
Glossodynia 31.39 14.78 58 12701 103279 79628350
Helicobacter infection 28.97 14.78 45 12714 69659 79661970
Sleep disorder due to general medical condition, insomnia type 28.49 14.78 35 12724 43521 79688108
Lower limb fracture 26.40 14.78 25 12734 23190 79708439
Hand deformity 26.29 14.78 54 12705 103865 79627764
Folliculitis 26.22 14.78 38 12721 55342 79676287
Nail bed tenderness 25.69 14.78 7 12752 407 79731222
Liver injury 24.16 14.78 37 12722 56577 79675052
Systemic lupus erythematosus 23.92 14.78 57 12702 121092 79610537
Heart sounds 23.73 14.78 8 12751 958 79730671
Pemphigus 23.16 14.78 50 12709 99532 79632097
Blood cholesterol increased 22.96 14.78 45 12714 83675 79647954
Psoriatic arthropathy 22.71 14.78 43 12716 77956 79653673
Vaginal flatulence 22.31 14.78 10 12749 2565 79729064
Lymphatic disorder 22.28 14.78 6 12753 334 79731295
Hip arthroplasty 22.21 14.78 28 12731 35728 79695901
Toxicity to various agents 22.03 14.78 21 12738 421519 79310110
Swelling 21.64 14.78 80 12679 216631 79514998
Prolonged expiration 21.58 14.78 8 12751 1263 79730366
Irritable bowel syndrome 21.55 14.78 37 12722 62204 79669425
Wound 21.17 14.78 53 12706 116126 79615503
Septic arthritis staphylococcal 21.05 14.78 7 12752 804 79730825
Prescribed overdose 20.93 14.78 28 12731 37855 79693774
Facet joint syndrome 20.70 14.78 16 12743 11286 79720343
Fibromyalgia 20.66 14.78 37 12722 64303 79667326
Staphylococcal skin infection 19.87 14.78 8 12751 1576 79730053
Anti-cyclic citrullinated peptide antibody positive 19.62 14.78 42 12717 83101 79648528
Wheezing 18.97 14.78 51 12708 116613 79615016
Liver disorder 18.75 14.78 38 12721 72379 79659250
Muscle injury 18.32 14.78 30 12729 48531 79683098
Impaired healing 18.12 14.78 42 12717 87613 79644016
Knee arthroplasty 18.08 14.78 28 12731 43220 79688409
Therapy non-responder 17.75 14.78 43 12716 92262 79639367
Ill-defined disorder 17.57 14.78 35 12724 65840 79665789
Infusion related reaction 17.42 14.78 78 12681 230159 79501470
Female genital tract fistula 16.83 14.78 11 12748 5964 79725665
Staphylococcal scalded skin syndrome 16.70 14.78 5 12754 408 79731221
Dyspepsia 16.17 14.78 46 12713 108641 79622988
Maternal exposure during pregnancy 15.86 14.78 53 12706 136485 79595144
Slow response to stimuli 15.53 14.78 7 12752 1818 79729811
Autonomic neuropathy 15.28 14.78 7 12752 1888 79729741
Retinitis 14.95 14.78 10 12749 5633 79725996
Dry mouth 14.83 14.78 39 12720 87980 79643649

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A01AB08 ALIMENTARY TRACT AND METABOLISM
STOMATOLOGICAL PREPARATIONS
STOMATOLOGICAL PREPARATIONS
Antiinfectives and antiseptics for local oral treatment
ATC A07AA01 ALIMENTARY TRACT AND METABOLISM
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
INTESTINAL ANTIINFECTIVES
Antibiotics
ATC A07AA51 ALIMENTARY TRACT AND METABOLISM
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
INTESTINAL ANTIINFECTIVES
Antibiotics
ATC B05CA09 BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
IRRIGATING SOLUTIONS
Antiinfectives
ATC D06AX04 DERMATOLOGICALS
ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
ANTIBIOTICS FOR TOPICAL USE
Other antibiotics for topical use
ATC J01GB05 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
AMINOGLYCOSIDE ANTIBACTERIALS
Other aminoglycosides
ATC R02AB01 RESPIRATORY SYSTEM
THROAT PREPARATIONS
THROAT PREPARATIONS
Antibiotics
ATC S01AA03 SENSORY ORGANS
OPHTHALMOLOGICALS
ANTIINFECTIVES
Antibiotics
ATC S02AA07 SENSORY ORGANS
OTOLOGICALS
ANTIINFECTIVES
Antiinfectives
ATC S03AA01 SENSORY ORGANS
OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
ANTIINFECTIVES
Antiinfectives
FDA CS M0000946 Aminoglycosides
FDA EPC N0000175477 Aminoglycoside Antibacterial
MeSH PA D000900 Anti-Bacterial Agents
MeSH PA D000890 Anti-Infective Agents
MeSH PA D004791 Enzyme Inhibitors
MeSH PA D011500 Protein Synthesis Inhibitors
CHEBI has role CHEBI:36047 antibacterial drugs
CHEBI has role CHEBI:50904 alergeno

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Otitis externa indication 3135009
Keratitis indication 5888003 DOID:4677
Hepatic encephalopathy indication 13920009 DOID:13413
Urinary tract infectious disease indication 68566005
Blepharoconjunctivitis indication 68659002 DOID:2456
Hepatic coma indication 72836002 DOID:12550
Corneal abrasion indication 85848002
Uveitis indication 128473001 DOID:13141
Infective blepharitis indication 312219000
Bacterial keratitis indication 314557000
Minor Skin Wound Pain indication
Superficial Ocular Infection indication
Mastoidectomy Cavity Infections indication
Preoperative Bowel Preparation indication
Minor Bacterial Skin Infections indication
Chronic purulent otitis media off-label use 38394007 DOID:14247
Bacterial conjunctivitis off-label use 128350005 DOID:9700
Ocular hypertension contraindication 4210003 DOID:9282
Hypocalcemia contraindication 5291005
Herpes simplex keratitis contraindication 9389005
Herpes zoster auricularis contraindication 21954000 DOID:9210
Hypovolemia contraindication 28560003
Herpes simplex dendritic keratitis contraindication 29943008
Fungal infection of eye contraindication 31194008
Parkinsonism contraindication 32798002
Bullous myringitis contraindication 33528003 DOID:13791
Dehydration contraindication 34095006
Severe myopia contraindication 34187009
Tuberculosis of eye contraindication 49107007
Neuromuscular block, function contraindication 55394004
Perforation of tympanic membrane contraindication 60442001
Tinnitus contraindication 60862001
Diabetes mellitus contraindication 73211009 DOID:9351
Third degree burn injury contraindication 80247002
Open-angle glaucoma contraindication 84494001 DOID:1067
Krukenberg spindle contraindication 85430004
Ulceration of intestine contraindication 85942002
Herpes simplex contraindication 88594005 DOID:8566
Kidney disease contraindication 90708001 DOID:557
Myasthenia gravis contraindication 91637004 DOID:437
Procedure on urinary system contraindication 118677009
Open wound contraindication 125643001
Gastrointestinal obstruction contraindication 126765001
Eye infection contraindication 128351009
Hearing disorder contraindication 128540005
Bacterial infection of eye contraindication 128984004
Tuberculosis of ear contraindication 186269001
Toxic nephropathy contraindication 236514003
Telangiectasia disorder contraindication 247479008
Rupture of bladder contraindication 251925007
Injury of eye region contraindication 282752000
Pregnancy, function contraindication 289908002
Viral eye infection contraindication 312132001
Viral ear infection contraindication 312137007
Fungal ear infection contraindication 312148000
Adrenal cortical hypofunction contraindication 386584007 DOID:10493
Vaccinia keratitis contraindication 397552005
Vertigo contraindication 399153001
Atrophoderma contraindication 399979006
Peripheral vascular disease contraindication 400047006
Infant Botulism contraindication
Auditory Neurotoxicity contraindication
Disorder of the 8th Cranial Nerve contraindication




🐶 Veterinary Drug Use

SpeciesUseRelation
Cats Bacterial infections Indication
Cats Wound infections Indication
Cats Superficial ocular bacterial infections limited to the conjunctival or the anterior segment of the eye Indication
Cattle Colibacillosis caused by Escherichia coli Indication
Dogs Bacterial infections Indication
Dogs Bacterial diarrhea Indication
Dogs Wound infections Indication
Dogs Superficial ocular bacterial infections limited to the conjunctival or the anterior segment of the eye Indication
Goats Colibacillosis caused by Escherichia coli Indication
Horses Ear and skin conditions caused by organisms Indication
Horses Ear and skin conditions caused by allergy Indication
Horses Superficial dressing applied to minor cuts Indication
Horses Superficial dressing applied to wounds Indication
Horses Superficial dressing applied to lacerations Indication
Horses Superficial dressing applied to abrasions Indication
Horses Superficial dressing for post-surgical application Indication
Sheep Colibacillosis caused by Escherichia coli Indication
Swine Colibacillosis caused by Escherichia coli Indication
Turkeys Control of mortality associated with Escherichia coli Indication

🐶 Veterinary products

ProductApplicantIngredients
Neo-Cortef with Tetracaine Zoetis Inc. 3
Neomix 325 Soluble Powder, Neomix AG 325 Soluble Powder Zoetis Inc. 1
Hydeltrone Ointment Boehringer lngelheim Animal Health USA Inc. 2
Neo-Delta-Cortef with Tetracaine Ointment Zoetis Inc. 3
Biosol Sterile Solution, Biosol Sterile Solution 50 mg Zoetis Inc. 1
Panolog Ointment Zoetis Inc. 4
Jenomycin Tablets Intervet Inc. 2
Neo-synalar Cream Bausch Health US LLC 2
Neo-Predef with Tetracaine Powder Zoetis Inc. 3
Neo-Predef with Tetracaine Top. Ointment, Tritop Topical Ointment Zoetis Inc. 3
Neo-Darbazine Spansule Capsule No.1, Neo-Darbazine Spansule Capsule No.3 Zoetis Inc. 3
Neo Predef Sterile Ointment Zoetis Inc. 2
Anaprime Ophthalmic Solution Zoetis Inc. 3
Kymar Ointment Improved Intervet Inc. 4
Tresaderm Dermatologic Solution Boehringer lngelheim Animal Health USA Inc. 3
Anaprime Opthakote Ophthalmic Zoetis Inc. 3
Optiprime Opthakote Ophthalmic Solution Zoetis Inc. 2
Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment, Vetropolycin HC Ophthalmic Ointment Dechra, Ltd. 4
Bac-Neo-Poly Ophthalmic Ointment, Vetropolycin Ophthalmic Ointment Dechra, Ltd. 3
Mycitracin Sterile Ophthalmic Ointment Zoetis Inc. 3
Forte Topical Ointment Zoetis Inc. 4
Cortisporin Veterinary Ophthalmic Ointment Intervet Inc. 4
Neosporin Ophthalmic Ointment Intervet Inc. 3
Neo-Delta Cortef Sterile Solution Zoetis Inc. 2
Neo-Cortef Sterile Ointment Zoetis Inc. 2
Neo-Terramycin 100/100, Neo-Terramycin 100/100D, Neo-Terramycin 50/50, Neo-Terramycin 50/50D Phibro Animal Health Corp. 2
Panolog Cream Zoetis Inc. 4
Neo-Oxy 100/100 MR, Neo-Oxy 50/50 Pharmgate Inc. 2
DERMA-VET Ointment Med-Pharmex Inc. 4
Animax Ointment Fougera Pharmaceuticals Inc. 4
Derma 4 Ointment Zoetis Inc. 4
Neomix Ag 325 Medicated Premix, Neomix 325 Medicated Premix Zoetis Inc. 1
Derm-Otic Ointment Zoetis Inc. 4
Neomycin Sulfate Zoetis Inc. 1
NeoMed Soluble Powder Bimeda Animal Health Limited 1
Biosol Liquid Zoetis Inc. 1
Neomycin Oral Solution Huvepharma EOOD 1
Neo-Sol 50 Huvepharma EOOD 1
Neo 200 Oral Solution Huvepharma EOOD 1
Neosol Soluble Powder Med-Pharmex Inc. 1
Derma-Vet Cream Med-Pharmex Inc. 4
Neosol-Oral Med-Pharmex Inc. 1
Animax Cream Fougera Pharmaceuticals Inc. 4
Neomycin Sulfate 325 Sparhawk Laboratories Inc. 1
Neomycin Liquid Sparhawk Laboratories Inc. 1
Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment Akorn Animal Health Inc. 3
Thiabendazole, Dexamethasone, Neomycin Sulfate Solution Dechra Veterinary Products LLC 3

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Transient receptor potential cation channel subfamily V member 1 Ion channel IC50 6.40 CHEMBL
Lecithin retinol acyltransferase Enzyme IC50 4.83 CHEMBL
Menin Unclassified Kd 4.81 CHEMBL
Lethal factor Enzyme Ki 6.30 CHEMBL
Extracellular calcium-sensing receptor GPCR AGONIST Kd 4 IUPHAR

External reference:

IDSource
4018765 VUID
N0000178941 NUI
D01618 KEGG_DRUG
4017501 VANDF
4017991 VANDF
4018765 VANDF
C0027603 UMLSCUI
CHEBI:7507 CHEBI
NMY PDB_CHEM_ID
CHEMBL3989751 ChEMBL_ID
CHEMBL3989769 ChEMBL_ID
D009355 MESH_DESCRIPTOR_UI
DB00994 DRUGBANK_ID
709 IUPHAR_LIGAND_ID
232 INN_ID
I16QD7X297 UNII
8378 PUBCHEM_CID
7299 RXNORM
2184 MMSL
35157 MMSL
5163 MMSL
5164 MMSL
d00312 MMSL
002775 NDDF
002777 NDDF
373528008 SNOMEDCT_US
70961008 SNOMEDCT_US
73093001 SNOMEDCT_US
96026000 SNOMEDCT_US
CHEMBL3989533 ChEMBL_ID
1404-04-2 SECONDARY_CAS_RN
55298-68-5 SECONDARY_CAS_RN

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
MAXITROL HUMAN PRESCRIPTION DRUG LABEL 3 0065-0631 OINTMENT 3.50 mg OPHTHALMIC NDA 18 sections
MAXITROL HUMAN PRESCRIPTION DRUG LABEL 3 0078-0771 OINTMENT 3.50 mg OPHTHALMIC NDA 18 sections
MAXITROL HUMAN PRESCRIPTION DRUG LABEL 3 0078-0771 OINTMENT 3.50 mg OPHTHALMIC NDA 18 sections
MAXITROL HUMAN PRESCRIPTION DRUG LABEL 3 0078-0771 OINTMENT 3.50 mg OPHTHALMIC NDA 18 sections
Maxitrol HUMAN PRESCRIPTION DRUG LABEL 3 0078-0792 SUSPENSION 3.50 mg OPHTHALMIC NDA 18 sections
Neomycin Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0093-1177 TABLET 500 mg ORAL ANDA 22 sections
Neomycin Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0093-1177 TABLET 500 mg ORAL ANDA 22 sections
Neomycin Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0093-1177 TABLET 500 mg ORAL ANDA 22 sections
Good Sense First Aid Antibiotic HUMAN OTC DRUG LABEL 3 0113-0084 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Good Sense Triple Antibioticand Pain Relief HUMAN OTC DRUG LABEL 4 0113-0679 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
basic care first aid antibiotic HUMAN OTC DRUG LABEL 3 0113-0701 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
good sense triple antibiotic HUMAN OTC DRUG LABEL 4 0113-1140 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Basic Care First Aid Antibiotic Plus Pain Relief HUMAN OTC DRUG LABEL 4 0113-7679 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
AntibioticMaximum Strength HUMAN OTC DRUG LABEL 3 0363-0018 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
AntibioticMaximum Strength HUMAN OTC DRUG LABEL 3 0363-0018 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Triple Antibiotic with Pain ReliefMaximum Strength HUMAN OTC DRUG LABEL 4 0363-0123 OINTMENT 3.50 mg TOPICAL OTC MONOGRAPH FINAL 13 sections
Triple Antibiotic HUMAN OTC DRUG LABEL 3 0363-0179 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Triple Antibiotic HUMAN OTC DRUG LABEL 3 0363-0179 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Triple Antibiotic HUMAN OTC DRUG LABEL 3 0363-0179 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
triple antibiotic HUMAN OTC DRUG LABEL 3 0363-0539 OINTMENT 3.50 mg TOPICAL OTC monograph final 15 sections
triple antibiotic HUMAN OTC DRUG LABEL 3 0363-0539 OINTMENT 3.50 mg TOPICAL OTC monograph final 15 sections
triple antibiotic HUMAN OTC DRUG LABEL 3 0363-0539 OINTMENT 3.50 mg TOPICAL OTC monograph final 15 sections
First Aid Antibiotic HUMAN OTC DRUG LABEL 4 0363-0841 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
First Aid Antibiotic HUMAN OTC DRUG LABEL 4 0363-0841 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Walgreens Triple Antibiotic HUMAN OTC DRUG LABEL 3 0363-2016 OINTMENT 3.50 mg TOPICAL OTC MONOGRAPH FINAL 14 sections
Walgreens Kids Multi-Antibiotic with Pain Relief Cream HUMAN OTC DRUG LABEL 3 0363-2122 CREAM 3.50 mg TOPICAL OTC monograph not final 11 sections
Walgreens Multi-Antibiotic with Pain Relief Cream HUMAN OTC DRUG LABEL 3 0363-2123 CREAM 3.50 mg TOPICAL OTC monograph not final 9 sections
Triple Antibiotic HUMAN OTC DRUG LABEL 4 0363-2900 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Triple Antibiotic HUMAN OTC DRUG LABEL 4 0363-2900 OINTMENT 3.50 mg TOPICAL OTC monograph final 13 sections
Walgreens Maximum Strength Triple Antibiotic With Pain Relief HUMAN OTC DRUG LABEL 4 0363-7872 OINTMENT 3.50 mg TOPICAL OTC monograph final 11 sections